Posted by Trevor Kearing on Jan 30th, 2026
Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are currently covering the stock, Marketbeat.com reports. One research analyst...
More of this article »